Clinical Trials Directory

Trials / Completed

CompletedNCT05127083

Oral Lichen Planus Treatment

Oral Lichen Planus Photodynamic Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Universidad de Murcia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oral lichen planus (OLP) is a chronic inflammatory and immune-mediated disease affecting the oral mucosa. OLP presents with asymptomatic, lacelike white stripes and/or symptomatic red, ulcerated mucous membranes. Eating, drinking and oral hygiene procedures may be painful resulting in reduced quality of life (QOL). Photodynamic therapy (PDT) is a new suggestion for OLP treatment PDT is a successful treatment mo- dality for premalignant and malignant diseases of head and neck,gastrointestinal tract, lung, and skin In this study, the effect of photodynamic therapy with topical corticosteroid in oral lichen planus patients was compared

Detailed description

In this study, the efficacy of toluidine blue-mediated photodynamic therapy and topical triamcinolone acetonide 0.2% on decreasing pain and size of OLP lesions was compared. This randomized, clinical trial compared the therapeutic effect of photodynamic therapy on symptomatic OLP (atrophic/ erosive/ulcerative forms) with triamcinolone acetonide 0.2%. The protocol of the clinical trial, which was conducted according to the ethical principles of Helsinki Group I toluidine blue-mediated photodynamic therapy Group II photodynamic therapy GroupIII laser sham + triamcinolone acetonide 0.2%

Conditions

Interventions

TypeNameDescription
RADIATIONPatients will be treated with localized PBM with a diode laserToluidine blue was applied on the lesions.The tissue were irradiated with a 660-nm diode laser InGaAlP

Timeline

Start date
2018-06-04
Primary completion
2020-10-03
Completion
2021-10-18
First posted
2021-11-19
Last updated
2021-11-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05127083. Inclusion in this directory is not an endorsement.